C4 Therapeutics, Inc.·4

Oct 5, 9:00 PM ET

COHEN MARC A 4

4 · C4 Therapeutics, Inc. · Filed Oct 5, 2020

Insider Transaction Report

Form 4
Period: 2020-10-01
COHEN MARC A
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-10-01+17,78617,786 total
    Exercise: $19.00Exp: 2030-09-30Common Stock (17,786 underlying)
  • Award

    Stock Option (Right to Buy)

    2020-10-01+725,002725,002 total
    Exercise: $19.00Exp: 2030-09-30Common Stock (725,002 underlying)
Footnotes (2)
  • [F1]12.5% of this option shall vest and become exercisable on April 1, 2021, with the remainder vesting in 14 equal quarterly installments thereafter.
  • [F2]This option shall vest and become exercisable upon the earlier to occur of (i) October 1, 2021, and (ii) the next annual meeting of the Issuer's stockholders.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION